Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

Journal of the American Geriatrics Society

Volumn 47, Issue 6, 1999, Pages 716-719

  Jeste, Dilip V ^a,b,c   Lacro, Jonathan P ^a   Bailey, Anne ^a   Rockwell, Enid ^a   Harris, M Jackuelyn ^a   Caligiuri, Michael P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Aging; Dementia; Movement disorder; Neuroleptics; Psychosis

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADULT; AFFECTIVE NEUROSIS; AGING; ARTICLE; CAREGIVER; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MOTOR DYSFUNCTION; PSYCHOSIS; RATING SCALE; STATISTICAL ANALYSIS; TARDIVE DYSKINESIA;

EID: 0033065629     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb01595.x     Document Type: Article

References (23)

1. Kane JM, Jeste DV, Barnes TRE et al. Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association, 1992.
2. Jeste DV, Caligiuri MP. Tardive dyskinesia. Schizophr Bull 1993;19:303-315.
3. Kane JM, Woerner M, Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol 1988;8:52-56S.
4. Saltz BL, Woerner MG, Kane JM et al. Prospective study of tardive dyskinesia incidence in the elderly. JAMA 1991;266:2402-2406.
5. Jeste DV, Caligiuri MP, Paulsen JS et al. Risk of tardive dyskinesia in older patients: A prospective longitudinal study of 266 patients. Arch Gen Psychiatry 1995;52:756-765.
6. Jeste DV, Rockwell E, Harris MJ et al. Conventional versus newer antipsychotics in elderly: Am J Geriatr Psychiatry 1999;7:70-76.
7. Lieberman JA, Saltz BL, Johns CA et al. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991;158:503-510.
8. Tollefson GD, Beasley CM, Tamura RN et al. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997;154:1248-1254.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. Washington, DC: American Psychiatric Press, 1987.
10. Lake JT, Rahman AH, Grossberg GT. Diagnosis and treatment of psychotic symptoms in elderly patients. Drugs Aging 1997;11:170-177.
11. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835.
12. Caligiuri MP, Lacro JP, Jeste DV. Incidence and predictors of drug-induced Parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. J Clin Psychopharmacol 1999, in press.
13. American Psychiatric Association. Medication-induced movement disorders. In: Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association, 1994, pp 678-680.
14. National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). Early Clin Drug Eval Unit Intercom 1975;4:3-6.
15. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212(suppl):11-19.
16. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull 1988;24: 97-99.
17. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Schooler N, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982;39:486-487.
19. Jeste DV, Lacro JP, Palmer B, et al. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry 1999;156:309-311.
20. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Disord 1958;8:669-712.
21. Cox DR. Regression models and life tables. J R Stat Soc, Series B 1972;34: 187-220.
22. Dixon W J. BMDP. Statistical Software Manual, Vols 1 and 2. Berkeley: University of California Press, 1992.
23. Ganzini L, Heintz RT, Hoffman WF et al. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics: A controlled study: Arch Gen Psychiatry 1991;48:259-263.